• Emmy Boerrigter on dose selection of novel anticancer drugs

  • Jul 29 2024
  • Length: 12 mins
  • Podcast

Emmy Boerrigter on dose selection of novel anticancer drugs By cover art

Emmy Boerrigter on dose selection of novel anticancer drugs

Listen for free

View show details

  • Summary

  • Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.

    Read the full article:
    https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00134-7?dgcid=buzzsprout_icw_podcast_generic_lanonc

    Tell us what you thought about this episode

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living Biological Sciences
Show more Show less

What listeners say about Emmy Boerrigter on dose selection of novel anticancer drugs

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available